Scheltens, Philip

Imaging of Static Brain Lesions in Vascular Dementia: Implications for Clinical Trials

Erkinjuntti, T., Bowler, J. V., DeCarli, C. S., Fazekas, F., Inzitari, D., O??Brien, J. T., Pantoni, L., Rockwood, K., Scheltens, P., Wahlund, L.-O., et al. (1999) · Alzheimer Disease & Associated Disorders

Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

Cited by 62

PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment

(ADNI), A. D. N. I., Kleineidam, L., Chouraki, V., Próchnicki, T., van der Lee, S. J., Madrid-Márquez, L., Wagner-Thelen, H., Karaca, I., Weinhold, L., Wolfsgruber, S., et al. (2020) · Acta Neuropathologica

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 62

A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer’s disease

Skillbäck, T., Mattsson, N., Hansson, K., Mirgorodskaya, E., Dahlén, R., van der Flier, W., Scheltens, P., Duits, F., Hansson, O., Teunissen, C., et al. (2017) · Scientific Reports

Advanced Proteomics Techniques and ApplicationsAlzheimer's disease research and treatments

Cited by 61

Tolerability and Safety of Souvenaid in Patients with Mild Alzheimer’s Disease: Results of Multi-Center, 24-Week, Open-Label Extension Study

Olde Rikkert, M. G. M., Verhey, F. R., Blesa, R., von Arnim, C. A. F., Bongers, A., Harrison, J., Sijben, J., Scarpini, E., Vandewoude, M. F. J., Vellas, B., et al. (2015) · Journal of Alzheimer s Disease

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 61

Gray matter network disruptions and amyloid beta in cognitively normal adults

Tijms, B. M., Kate, M. T., Wink, A. M., Visser, P. J., Ecay, M., Clerigue, M., Estanga, A., Garcia Sebastian, M., Izagirre, A., Villanua, J., et al. (2016) · Neurobiology of Aging

Functional Brain Connectivity StudiesDementia and Cognitive Impairment Research

Cited by 59

A longitudinal study on resting state functional connectivity in behavioral variant frontotemporal dementia and Alzheimer’s disease

Hafkemeijer, A., Möller, C., Dopper, E. G. P., Jiskoot, L. C., van den Berg-Huysmans, A. A., van Swieten, J. C., van der Flier, W. M., Vrenken, H., Pijnenburg, Y. A. L., Barkhof, F., et al. (2016) · Journal of Alzheimer’s Disease

Functional Brain Connectivity StudiesDementia and Cognitive Impairment Research

Cited by 57

The Pitfall of Behavioral Variant Frontotemporal Dementia Mimics Despite Multidisciplinary Application of the FTDC Criteria

Krudop, W. A., Dols, A., Kerssens, C. J., Eikelenboom, P., Prins, N. D., Möller, C., Schouws, S., Rhebergen, D., van Exel, E., van der Flier, W. M., et al. (2017) · Journal of Alzheimer's Disease

Dementia and Cognitive Impairment ResearchHistorical and Modern Theater Studies

Cited by 57

Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer's Disease in the European Prospective DESCRIPA Study

Damian, M., Hausner, L., Jekel, K., Richter, M., Froelich, L., Almkvist, O., Boada, M., Bullock, R., De Deyn, P. P., Frisoni, G. B., et al. (2013) · Dementia and Geriatric Cognitive Disorders

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 53

Complexity of MRI white matter hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook Dementia Study

Gao, F.-Q., Swartz, R. H., Scheltens, P., Leibovitch, F. S., Kiss, A., Honjo, K., & Black, S. E. (2011) · Journal of Alzheimer's Disease

Dementia and Cognitive Impairment ResearchCerebrovascular and genetic disorders

Cited by 50

Progression of Alzheimer disease in Europe: data from the European ICTUS study

Vellas, B., Hausner, L., Frolich, L., Cantet, C., Gardette, V., Reynish, E., Gillette, S., Aguera-Morales, E., Auriacombe, S., Boada, M., et al. (2012) · Current Alzheimer Research

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 50

SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease

Ramirez, A., van der Flier, W. M., Herold, C., Ramonet, D., Heilmann, S., Lewczuk, P., Popp, J., Lacour, A., Drichel, D., Louwersheimer, E., et al. (2014) · Human Molecular Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 49

Social cognition differentiates behavioral variant frontotemporal dementia from other neurodegenerative diseases and psychiatric disorders

Gossink, F., Schouws, S., Krudop, W., Scheltens, P., Stek, M., Pijnenburg, Y., & Dols, A. (2018) · The American Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchHistorical and Modern Theater Studies

Cited by 49

Single subject classification of Alzheimer’s disease and behavioral variant frontotemporal dementia using anatomical, diffusion tensor, and resting-state functional magnetic resonance imaging.

Bouts, M. J. R. J., Möller, C., Hafkemeijer, A., van Swieten, J. C., Dopper, E., van der Flier, W. M., Vrenken, H., Wink, A. M., Pijnenburg, Y. A. L., Scheltens, P., et al. (2018) · Journal of Alzheimer’s Disease

Dementia and Cognitive Impairment ResearchFunctional Brain Connectivity Studies

Cited by 47

Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project

Initiative, F. T. A. D. N., van Maurik, I. S., Slot, R. E. R., Verfaillie, S. C. J., Zwan, M. D., Bouwman, F. H., Prins, N. D., Teunissen, C. E., Scheltens, P., Barkhof, F., et al. (2019) · Alzheimer's Research & Therapy

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 47

Heterogeneous language profiles in patients with primary progressive aphasia due to Alzheimer's disease

Louwersheimer, E., Keulen, M. A., Steenwijk, M. D., Wattjes, M. P., Jiskoot, L. C., Vrenken, H., Teunissen, C. E., van Berckel, B. N. M., van der Flier, W. M., Scheltens, P., et al. (2016) · Journal of Alzheimer's Disease

Dementia and Cognitive Impairment ResearchNeurobiology of Language and Bilingualism

Cited by 46

Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset

Homann, J., Osburg, T., Ohlei, O., Dobricic, V., Deecke, L., Bos, I., Vandenberghe, R., Gabel, S., Scheltens, P., Teunissen, C. E., et al. (2022) · Frontiers in Aging Neuroscience

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 46

The added value of 18-fluorodeoxyglucose-positron emission tomography in the diagnosis of the behavioral variant of frontotemporal dementia

Kerklaan, B. J., van Berckel, B. N. M., Herholz, K., Dols, A., van der Flier, W. M., Scheltens, P., & Pijnenburg, Y. A. L. (2014) · American Journal of Alzheimer's Disease & Other Dementias®

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 46

Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders

Vijverberg, E. G. B., Dols, A., Krudop, W. A., Del Campo Milan, M., Kerssens, C. J., Gossink, F., Prins, N. D., Stek, M. L., Scheltens, P., Teunissen, C. E., et al. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 46

Kinetics and 28-day test–retest repeatability and reproducibility of [ 11 C]UCB-J PET brain imaging

Tuncel, H., Boellaard, R., Coomans, E. M., de Vries, E. F., Glaudemans, A. W., Feltes, P. K., García, D. V., Verfaillie, S. C., Wolters, E. E., Sweeney, S. P., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism

Dementia and Cognitive Impairment ResearchMedical Imaging Techniques and Applications

Cited by 45

Clinical recognition of frontotemporal dementia with right anterior temporal predominance: A multicenter retrospective cohort study

Ulugut, H., Bertoux, M., Younes, K., Montembeault, M., Fumagalli, G. G., Samanci, B., Illán‐Gala, I., Kuchcinski, G., Leroy, M., Thompson, J. C., et al. (2024) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchHistorical and Modern Theater Studies

Cited by 43

Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: An age‐continuous perspective

Zhang, M., Ganz, A. B., Rohde, S., Rozemuller, A. J. M., Bank, N. B., Reinders, M. J. T., Scheltens, P., Hulsman, M., Hoozemans, J. J. M., & Holstege, H. (2023) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 43

Diagnostic and prognostic value of EEG in prodromal dementia with Lewy bodies

van der Zande, J. J., Gouw, A. A., van Steenoven, I., van de Beek, M., Scheltens, P., Stam, C. J., & Lemstra, A. W. (2020) · Neurology

Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments

Cited by 43

Gray Matter Network Disruptions and Regional Amyloid Beta in Cognitively Normal Adults

ten Kate, M., Visser, P. J., Bakardjian, H., Barkhof, F., Sikkes, S. A. M., van der Flier, W. M., Scheltens, P., Hampel, H., Habert, M.-O., Dubois, B., et al. (2018) · Frontiers in Aging Neuroscience

Dementia and Cognitive Impairment ResearchFunctional Brain Connectivity Studies

Cited by 41

Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer’s Disease

van Harten, A. C., Mulders, J., Scheltens, P., van der Flier, W. M., & Oudejans, C. B. M. (2015) · Journal of Alzheimer's Disease

MicroRNA in disease regulationDementia and Cognitive Impairment Research

Cited by 41